Brainstorm Cell Therapeutics reported $-6858000 in Net Income for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Biogen BIIB:US USD 1.13B 76.7M
Brainstorm Cell Therapeutics BCLI:US USD -6858000 183K
Cytokinetics CYTK:US USD -142310000 122.49M
Gilead Sciences GILD:US USD 1.64B 149M
Halozyme Therapeutics HALO:US USD 61.63M 38.95M
Idera Pharmaceuticals IDRA:US USD -3099000 2.21M